CELU Celularity Inc.: צמיחת הכנסות רבעונית

Collaboration with scientific centers specializing in placental therapy creates a strong foundation for Celularity Inc. (CELU). This quarterly revenue chart visualizes this potential, where the -5.20 mark records this metric. Revenues are based on the sale of biomaterials and the preparation of cancer drugs. The readiness of biobanks for mass production confirms the technical resilience of the business.
Celularity Corp - פילוחים אנליטיים ומדדי מפתח (CELU)

This metric tracks the percentage deviation of current sales volume from the same period last year, enabling the identification of structural shifts in revenue before a change in the market cycle. For Celularity Inc. (CELU), this indicator reflects the pace of cell therapy commercialization within the protected US legal framework, making the quarterly revenue change history the basis for assessing the real scaling of the business.